mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032477/
WEBMay 5, 2021 · The efficacy of these mRNA vaccines developed by BioNTech/Pfizer and Moderna is about 95% ( Baden et al., 2021; Polack et al., 2020) and they were the first … Author: Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke, Gideon Kersten, Wim Jiskoot... DOI: 10.1016/j.ijpharm.2021.120586 Publish Year: 2021 Publication: Int J Pharm. 2021 May 15; 601: 120586.
Author: Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni, Rein Verbeke, Gideon Kersten, Wim Jiskoot...
DOI: 10.1016/j.ijpharm.2021.120586
Publish Year: 2021
Publication: Int J Pharm. 2021 May 15; 601: 120586.
DA: 36 PA: 62 MOZ Rank: 9